Uvéites et médecine interne : stratégies diagnostique et thérapeutique
Tóm tắt
Từ khóa
Tài liệu tham khảo
Gritz, 2004, Incidence and prevalence of uveitis in Northern California: the Northern California epidemiology of uveitis study, Ophthalmology, 111, 491, 10.1016/j.ophtha.2003.06.014
Suttorp-Schulten, 1996, The possible impact of uveitis in blindness: a literature survey, Br J Ophthalmol, 80, 844, 10.1136/bjo.80.9.844
Jabs, 2005, Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop, Am J Ophthalmol, 140, 509, 10.1016/j.ajo.2005.03.057
Rothova, 1996, Causes and frequency of blindness in patients with intraocular inflammatory disease, Br J Ophthalmol, 80, 332, 10.1136/bjo.80.4.332
Bodaghi, 2001, Chronic severe uveitis etiology and visual outcome in 927 patients from a single center, Medicine, 80, 263, 10.1097/00005792-200107000-00005
Monnet, 2004, Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 Uveitis, Ophthalmology, 111, 802, 10.1016/j.ophtha.2003.07.011
Rudwaleit, 2004, How to diagnose axial spondylathritis early?, Ann Rheum Dis, 63, 535, 10.1136/ard.2003.011247
1990, Evaluation of diagnostic (classification) criteria in Behçet’s disease: toward internationally agreed criteria, Lancet, 335, 1078
Tugal-Tutkun, 2004, Uveitis in Behçet disease: an analysis of 880 patients, Am J Ophthalmol, 138, 373, 10.1016/j.ajo.2004.03.022
Abad, 2008, Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations and HLA genotype data, Ocul Inflamm Immunol, 16, 3, 10.1080/09273940801923895
Read, 2001, Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature, Am J Ophthalmol, 131, 647, 10.1016/S0002-9394(01)00925-4
Mandeville, 2001, The tubulointerstitial nephritis and uveitis syndrome, Surv Ophthalmol, 46, 195, 10.1016/S0039-6257(01)00261-2
Park, 2004, Pseudo-uveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients, Medicine (Baltimore), 83, 223, 10.1097/01.md.0000134850.35118.46
Finger, 2006, Anterior chamber paracentesis cytology (cytospin technique) for the diagnosis in intraocular lymphoma, Br J Ophthalmol, 90, 690, 10.1136/bjo.2005.087346
Karma, 2007, Primary intraocular lymphoma: improving the diagnostic procedure, Ophthalmology, 114, 1372, 10.1016/j.ophtha.2006.11.009
Cassoux, 2007, IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma, Invest Ophthalmol Vis Sci, 48, 3253, 10.1167/iovs.06-0031
Lardenoy, 1997, Peripheral multifocal chorioretinitis. A distinct clinical entity?, Ophthalmology, 104, 1820, 10.1016/S0161-6420(97)30021-9
Kaiser, 2002, Chest computed tomography in the evaluation of uveitis in elderly women, Am J Ophthalmol, 133, 499, 10.1016/S0002-9394(02)01333-8
Nishiyama, 2006, Comparative evaluation of 18F-FDG PET and 67Ga scintigraphy in patients with sarcoidosis, J Nucl Med, 47, 1571
P Sève, C Billotey, L Varron, M Janier, JD Grange, C Broussolle, et al. Fluorodeoxyglucose positron emission tomography for the diagnosis of suspected uveitis-associated sarcoidosis in patients with normal chest computerized tomography. International Ocular Inflammation Society, 9th Congress, Paris, September 2007.
Abad, 2004, Association of peripheral multifocal choroiditis with sarcoidosis? A study of 37 patients, Arthritis Rheum, 51, 974, 10.1002/art.20839
Morimura, 2002, Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan, Ophthalmology, 109, 851, 10.1016/S0161-6420(02)00973-9
Donahue, 1994, Intraocular candidiasis in patients with candidemia: clinical implications derived from a prospective multicenter study, Ophthalmology, 101, 1302, 10.1016/S0161-6420(94)31175-4
Stewart, 2005, Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis, Retina, 25, 1005, 10.1097/00006982-200512000-00009
Bugage, 2003, Ocular manifestations of human T-cell lymphotropic virus type 1 infection, Curr Opin Ophthalmol, 14, 420, 10.1097/00055735-200312000-00016
Dabil, 2001, Validation of a diagnostic multiplex polymerase chain reaction assay for infectious posterior uveitis, Arch Ophthalmol, 119, 1315, 10.1001/archopht.119.9.1315
Chee, 2008, Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients, Am J Ophthalmol, 145, 834, 10.1016/j.ajo.2007.12.015
Westeneng, 2007, Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis, Am J Ophthalmol, 144, 781, 10.1016/j.ajo.2007.06.034
Ortega-Larrocea, 2003, Nested polymerase chain reaction for Mycobacterium tuberculosis DNA detection in aqueous and vitreous of patients with uveitis, Arch Med Res, 34, 116, 10.1016/S0188-4409(02)00467-8
Bodaghi, 1998, Whipple’s syndrome (uveitis, B27-negative spondylarthropathy, meningitis, and lymphadenopathy) associated with Arthrobacter sp. infection, Ophthalmology, 105, 1891, 10.1016/S0161-6420(98)91036-3
Acharya, 2006, Correlation between clinical suspicion and polymerase chain reaction verification of infectious vitritis, Am J Ophthalmol, 141, 584, 10.1016/j.ajo.2005.10.011
Kok, 2005, Outcome of intravitreal triamcinolone in uveitis, Ophthalmology, 112, 1916, 10.1016/j.ophtha.2005.06.009
Benitez-Del-Castillo, 2000, Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis, Eye, 14, 340, 10.1038/eye.2000.84
Muñoz-Fernández, 2003, Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period, J Rheumatol, 30, 1277
Samson, 2001, Methotrexate therapy for chronic noninfectious uveitis. Analysis of a case series of 160 patients, Ophthalmology, 108, 1134, 10.1016/S0161-6420(01)00576-0
Baughman, 2000, Methotrexate is steroid sparing in acute sarcoidosis: results of double blind, randomized trial, Sarcoidosis Vasc Diffuse Lung Dis, 17, 60
Baker, 2006, Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease, Br J Ophthalmol, 90, 1481, 10.1136/bjo.2006.097998
Dinning, 1986, An overview of ocular manifestations, 227
Yazici, 1990, A controlled trial of azathioprine in Behçet’s syndrome, N Engl J Med, 322, 281, 10.1056/NEJM199002013220501
Ozyazgan, 1992, Low dose cyclosporin A versus pulsed cyclosphosphamide in Behçet’s syndrome: a single masked trial, Br J Ophthalmol, 76, 241, 10.1136/bjo.76.4.241
Demiroglu, 2000, Interferon alfa-2b, colchicine, and benzathine penicillin in Behçet’s disease: a randomised trial, Lancet, 355, 605, 10.1016/S0140-6736(99)05131-4
Kötter, 2003, Human recombinant interferon alfa-2a for the treatment of Behçet’s disease with sight threatening posterior or panuveitis, Br J Ophthalmol, 87, 423, 10.1136/bjo.87.4.423
Bodaghi, 2007, Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients, Br J Ophthalmol, 91, 335, 10.1136/bjo.2006.101550
Sfikakis, 2004, Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades–Behçet disease, Ann Intern Med, 140, 404, 10.7326/0003-4819-140-5-200403020-00025
Ohno, 2004, Efficacy, safety, and pharmakokinetics of multiple administration of infliximab in Behçet’s disease with refractory uveoretinitis, J Rheumatol, 31, 1362
Tugal-Tutkun, 2005, Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine and corticosteroids in Behçet’s disease, Arthritis Rheum, 52, 2478, 10.1002/art.21231
Sfikakis, 2007, Anti-TNF therapy in the management of Behcet’s disease-review and basis for recommendations, Rheumatology, 46, 736, 10.1093/rheumatology/kem034
Suhler, 2005, A prospective trial of infliximab therapy for refractory uveitis, Arch Ophthalmol, 123, 903, 10.1001/archopht.123.7.903
Hochberg, 2005, The benefit/risk profile of TNF-blocking agents: findings of a consensus panel, Semin Arthritis Rheum, 34, 819, 10.1016/j.semarthrit.2004.11.006